(3-Methoxy-naphthalen)-2-yl- (1-benzyl-piperidin) 4-yl-acetate (SB-235753) was labelled with C-11 (t(1/2) = 20.4 min) as a putative radioligand for the non-invasive assessment of Dopamine D-4 receptors in vivo with positron emission tomography (PET). The precursor for the radiosynthesis 3-hydroxynaphthyl-2-[(N-benzyl)piperidyl]-acetate hydrochloride was prepared by a four-step synthesis starting from ethyl-4-pyridyl acetate. The radiolabelling consisted of methylation with [C-11]methyltriflate in dimethylformamide in the presence of potassium hydroxide. [C-11]SB-235753, was synthesised in 30 min with a radiochemical yield of 10 +/- 5% (EOS, non-decay corrected) with 99% radiochemical purity and specific radioactivity of 10 +/- 3 Ci/mu mol. Biodistribution studies in rats with [C-11]SB-235753 showed the uniform distribution of the tracer within different areas of the murine brain. At 30 min after injection 99% of the radioligand in plasma and 100% in cerebellum was metabolised. These findings-suggest that [C-11]SB-235753 can not be a suitable tracer for dopamine D-4 receptor studies with PET.

Matarrese, M., Soloviev, D., Moresco, R., Todde, S., Simonelli, P., Colombo, D., et al. (2000). Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 43(4), 359-374.

Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET

MORESCO, ROSA MARIA;TODDE, SERGIO CAMILLO;SIMONELLI, PASQUALE;COLOMBO, DANIELE;MAGNI, FULVIO;FAZIO, FERRUCCIO;KIENLE, MARZIA DONATELLA
2000

Abstract

(3-Methoxy-naphthalen)-2-yl- (1-benzyl-piperidin) 4-yl-acetate (SB-235753) was labelled with C-11 (t(1/2) = 20.4 min) as a putative radioligand for the non-invasive assessment of Dopamine D-4 receptors in vivo with positron emission tomography (PET). The precursor for the radiosynthesis 3-hydroxynaphthyl-2-[(N-benzyl)piperidyl]-acetate hydrochloride was prepared by a four-step synthesis starting from ethyl-4-pyridyl acetate. The radiolabelling consisted of methylation with [C-11]methyltriflate in dimethylformamide in the presence of potassium hydroxide. [C-11]SB-235753, was synthesised in 30 min with a radiochemical yield of 10 +/- 5% (EOS, non-decay corrected) with 99% radiochemical purity and specific radioactivity of 10 +/- 3 Ci/mu mol. Biodistribution studies in rats with [C-11]SB-235753 showed the uniform distribution of the tracer within different areas of the murine brain. At 30 min after injection 99% of the radioligand in plasma and 100% in cerebellum was metabolised. These findings-suggest that [C-11]SB-235753 can not be a suitable tracer for dopamine D-4 receptor studies with PET.
Articolo in rivista - Articolo scientifico
SB-235753; rat, biodistribution; dopamine D-4 antagonist; [(11)Cmethyltriflate; O-methylation; 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin-4-yl)-acetate, PET
English
2000
43
4
359
374
none
Matarrese, M., Soloviev, D., Moresco, R., Todde, S., Simonelli, P., Colombo, D., et al. (2000). Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 43(4), 359-374.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/15797
Citazioni
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 14
Social impact